Expression of the pNR-2/pS2 protein in diverse human epithelial tumours
1991

Expression of the pNR-2/pS2 Protein in Human Epithelial Tumours

Sample size: 25 publication Evidence: moderate

Author Information

Author(s): J.A. Henry, M.K. Bennett, N.H. Piggott, D.L. Levett, F.E.B. May, B.R. Westley

Primary Institution: University of Newcastle upon Tyne

Hypothesis

The pNR-2/pS2 protein may have a more general role in human epithelial neoplasia than previously realized.

Conclusion

The study found widespread expression of the pNR-2/pS2 protein in various malignant epithelial tumours, particularly in pancreatic, large bowel, gastric, and endometrial carcinomas.

Supporting Evidence

  • Positive staining for pNR-2/pS2 was found in 75% of pancreatic carcinomas.
  • 56% of gastric carcinomas showed positive staining for pNR-2/pS2.
  • Positive staining was significantly associated with mucinous differentiation in ovarian tumours.

Takeaway

This study looked at a protein called pNR-2/pS2 in different types of tumors and found it in many of them, especially in pancreatic and stomach cancers.

Methodology

The study used immunohistochemical staining on surgically resected tumours and biopsies to evaluate pNR-2/pS2 expression.

Limitations

The study relied on archival material, which limited the ability to perform receptor assays and analyze menopausal status effects.

Participant Demographics

The study included various epithelial tumours from both male and female patients, but specific demographics were not detailed.

Statistical Information

P-Value

<0.00001

Statistical Significance

p<0.00001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication